Search

Your search keyword '"Pileri Stefano A"' showing total 2,125 results

Search Constraints

Start Over You searched for: Author "Pileri Stefano A" Remove constraint Author: "Pileri Stefano A"
2,125 results on '"Pileri Stefano A"'

Search Results

1. Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology

2. Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior

4. Correction to: Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology

5. Lymphomatoid Papulosis With T-cell Receptor–Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid Papulosis

7. Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation

8. Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature

9. Primary effusion lymphoma associated with Human Herpes Virus-8 and Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a case report

10. EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda

11. Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study

15. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis

16. The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network

17. Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL

18. Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL

21. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

22. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS

23. The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade

24. Genetic and phenotypic attributes of splenic marginal zone lymphoma

25. Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma

27. Histiocytic Neoplasma

28. Myeloid Sarcoma

31. A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas

32. Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project

33. Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified

35. Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma

36. Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry

38. Targeted DNA Damage Boost with Loncastuximab Tesirine in Combination with PARP Inhibitors in Diffuse Large B-Cell Lymphoma

39. The ATR inhibitor elimusertib exhibits anti‐lymphoma activity and synergizes with the PI3K inhibitor copanlisib

40. Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcoma

42. Novel markers in pediatric-type follicular lymphoma

43. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas

44. Identifying and addressing unmet clinical needs in primary cutaneous B‐cell lymphoma: A consensus‐based paper from an ad‐hoc international panel

45. S147: EFFICACY AND SAFETY RESULTS OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME

46. A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis

49. Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi

Catalog

Books, media, physical & digital resources